Document Detail

Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients.
MedLine Citation:
PMID:  17328078     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To describe the clinical, laboratory, and radiographic manifestations of Takayasu arteritis (TA) in a cohort from the US, evaluate the response to interventions, remission and relapse rates, and disease progression, and compare these observations with those from other cohorts in the US, Japan, India, Italy, and Mexico. METHODS: Seventy-five patients were retrospectively studied using a uniform database that included clinical, laboratory, and imaging data. Vascular imaging studies were performed at least yearly to monitor disease progression. RESULTS: Common manifestations at disease onset included loss or asymmetry of pulses (57%), limb blood pressure discrepancy (53%), and bruits (53%). Eleven percent of patients were asymptomatic prior to disease diagnosis. Initial angiographic studies showed aortic abnormalities in 79% of patients and frequent involvement of the subclavian (65%) and carotid (43%) arteries.Ninety-three percent of longitudinally followed patients attained disease remission of any duration, but only 28% sustained remission of at least 6 months' duration after prednisone was tapered to <10 mg daily. Both angioplasty and vascular surgery were initially successful, but recurrent stenosis occurred in 78% of angioplasty and 36% of bypass/reconstruction procedures. More than two-thirds of patients had difficulty performing routine daily activities and approximately one-fourth of all patients were unable to work. Our cohort was similar to the National Institutes of Health, Italian, Japanese, and Mexican cohorts in terms of the predominance of female subjects and disease manifestations, but differed from the Indian cohort in that the latter group had a higher frequency of male subjects, abdominal aorta and renal artery involvement, and hypertension. CONCLUSION: Although improvement of symptoms in TA usually follows glucocorticoid therapy, relapses usually occur with dosage reduction. Attempts to restore vascular patency are often initially successful, but restenosis occurs frequently. Chronic morbidity and disability occur in most patients with TA in the US.
Kathleen Maksimowicz-McKinnon; Tiffany M Clark; Gary S Hoffman
Related Documents :
23555368 - Efficacy of elective intra-aortic balloon pump therapy for high-risk off-pump coronary ...
19741578 - Below-the-knee revascularization. advanced techniques.
11342998 - Long-term results of percutaneous thrombo-embolectomy in patients with infrainguinal em...
15706998 - Safety and feasibility of transradial coronary angioplasty in elderly patients.
10758378 - Mitral valve surgery in patients with severe left ventricular dysfunction.
23954558 - Intraoperative assessment of human spinal cord perfusion using near infrared spectrosco...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Arthritis and rheumatism     Volume:  56     ISSN:  0004-3591     ISO Abbreviation:  Arthritis Rheum.     Publication Date:  2007 Mar 
Date Detail:
Created Date:  2007-03-21     Completed Date:  2007-04-12     Revised Date:  2009-11-03    
Medline Journal Info:
Nlm Unique ID:  0370605     Medline TA:  Arthritis Rheum     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1000-9     Citation Subset:  AIM; IM    
Cleveland Clinic Foundation, Center for Vasculitis Care and Research, Cleveland, Ohio 44195, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Child, Preschool
Cohort Studies
Coronary Restenosis / drug therapy,  ethnology,  prevention & control
Drug Therapy, Combination
Glucocorticoids / therapeutic use*
Immunosuppressive Agents / therapeutic use*
India / ethnology
Italy / ethnology
Japan / ethnology
Longitudinal Studies
Mexico / ethnology
Middle Aged
Retrospective Studies
Takayasu Arteritis / complications,  drug therapy*,  ethnology,  pathology*
Treatment Outcome
United States / ethnology
Reg. No./Substance:
0/Glucocorticoids; 0/Immunosuppressive Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Primary necrotizing lymphocytic central nervous system vasculitis due to perforin deficiency in a fo...
Next Document:  A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic scler...